Cargando…
Cost‐effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration
AIMS: The objective of this paper is to assess whether cardiac contractility modulation (via the Optimizer System) plus standard of care (SoC) is a cost‐effective treatment for people with heart failure [New York Heart Association (NYHA) III, left ventricular ejection fraction of 25–45%, and narrow...
Autores principales: | Witte, Klaus, Hasenfuss, Gerd, Kloppe, Axel, Burkhoff, Daniel, Green, Michelle, Moss, Joe, Peel, Alison, Mealing, Stuart, Durand Zaleski, Isabelle, Cowie, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989288/ https://www.ncbi.nlm.nih.gov/pubmed/31997539 http://dx.doi.org/10.1002/ehf2.12526 |
Ejemplares similares
-
LBBAP in patients with normal intrinsic QRS duration: Electrical and mechanical characteristics
por: Wang, Shaoxian, et al.
Publicado: (2021) -
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart
por: Lehnart, Stephan E., et al.
Publicado: (2009) -
Maximizing QRS duration reduction in contemporary cardiac resynchronization therapy is feasible and shorter QRS duration is associated with better clinical outcome
por: Borgquist, Rasmus, et al.
Publicado: (2023) -
Marked prolongation of QRS duration after initiation of dronedarone therapy
por: Genz, Conrad, et al.
Publicado: (2014) -
Electrocardiographic QRS duration is influenced by body mass index and sex
por: Rao, Anupam C.A., et al.
Publicado: (2021)